Michael Gelband’s AMERISAFE AMSF Stock Holding History

Michael Gelband’s Portfolio AMSF Stock Details AMSF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$945K	Sell	27,920 -53,398	-66%	-$1.69M	0.01%	1091
2026 Q1	$2.71M	Buy	81,318 +41,214	+103%	+$1.49M	0.02%	652
2025 Q4	$1.54M	Buy	+40,104	New	+$1.62M	0.01%	848
2025 Q3	–	Sell	-16,276	Closed	-$712K	–	1504
2025 Q2	$712K	Buy	16,276 +10,876	+201%	+$513K	0.01%	1058
2025 Q1	$284K	Sell	5,400 -20,751	-79%	-$1.05M	﹤0.01%	1239
2024 Q4	$1.35M	Sell	26,151 -15,253	-37%	-$825K	0.01%	850
2024 Q3	$2M	Buy	41,404 +23,880	+136%	+$1.14M	0.01%	730
2024 Q2	$769K	Buy	+17,524	New	+$804K	0.01%	1104
2021 Q3	–	Sell	-11,751	Closed	-$701K	–	2070
2021 Q2	$701K	Buy	11,751 +3,933	+50%	+$250K	0.01%	1183
2021 Q1	$500K	Buy	+7,818	New	+$470K	0.01%	1360
2020 Q4	–	Sell	-9,816	Closed	-$563K	–	1927
2020 Q3	$563K	Buy	+9,816	New	+$618K	0.01%	952
2019 Q4	–	Sell	-6,896	Closed	-$456K	–	1506
2019 Q3	$456K	Buy	+6,896	New	+$457K	0.02%	703

Other funds holding AMSF

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Michael Gelband's AMSF Position: Q2 2026 in Review

Michael Gelband reduced its AMERISAFE (AMSF) stake by 66% in Q2 2026, selling an estimated $1.69M and leaving 27,920 shares worth $945K. The position accounts for 0.01% of the portfolio, ranked #1091.

Michael Gelband first reported a position in AMSF in Q3 2019 and has held it in 12 quarters since. The position peaked at $2.71M in Q1 2026. 214 funds tracked by Wall St. Rank hold AMSF as of Q2 2026.

Michael Gelband held 27,920 shares of AMERISAFE worth $945K as of Q2 2026.
Michael Gelband sold 53,398 AMERISAFE shares in Q2 2026, an estimated $1.69M.
AMERISAFE made up 0.01% of Michael Gelband's portfolio in Q2 2026, its #1091 holding.
Michael Gelband first reported a position in AMERISAFE in Q3 2019 and has held it in 12 quarters since.
Michael Gelband's AMERISAFE position peaked at $2.71M in Q1 2026.
214 funds tracked by Wall St. Rank held AMERISAFE as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.